Hjem › Seglcelle-anæmi › North Carolina
Seglcelle-anæmi kliniske forsøg i North Carolina
18 studier for Seglcelle-anæmi søger deltagere på steder i North Carolina.
Byer i North Carolina
Officiel studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- East Carolina University, Greenville
- Wake Forest University Baptist Medical Center, Winston-Salem
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- Duke University Medical Center, Durham
- Brody School of Medicine at East Carolina University, Greenville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Atrium Levine Children's/Atrium Health, Charlotte
- Duke University_Durham, Durham
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Duke Comprehen Sickle Cell, Durham
- Duke University Medical Center, Durham
- East Carolina Univ-Greenville, Greenville
- og 1 flere
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT06612268A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- Levine Cancer Insitute Carolinas Healthcare System, Charlotte
- East Carolina University, Greenville
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 12 til 55 · Alle køn · Opdateret 9. sep. 2026 · NCT06546670A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0033, Greenville
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06481306A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Clinical & Translational Research Center (CTRC), Chapel Hill
- UNC Health, Chapel Hill
- UNC Eastowne Medical Office Building - Consent Only, Chapel Hill
- og 4 flere
RekruttererFase 2/3
Alder 12 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill
- St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital, Charlotte
- East Carolina University Hemophilia Treatment Center, Greenville
- og 1 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- East Carolina University, Greenville
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT06699849Sickle Cell Clinical Research and Intervention Program
- Novant Health Hemby Children's Hospital, Charlotte
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 4. jun. 2026 · NCT02098863Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- UNC Children's Hospital (MRD HCT), Chapel Hill
- UNC Children's Hospital (NT-DMT), Chapel Hill
- Atrium Health (MRD-HCT), Charlotte
RekruttererObservationsstudie
Alder 3 til 20 · Alle køn · Opdateret 4. jun. 2026 · NCT06941389SickleFit Exercise and Nutrition Study
- Duke University, Durham
Rekrutterer
Alder 35 og opefter · Alle køn · Opdateret 7. maj 2026 · NCT07442851Predictors of Pain in Sickle Cell Disease
- Duke University Medical Center, Durham
Rekrutterer
Alder 15 til 40 · Alle køn · Opdateret 5. maj 2026 · NCT06139510ATHNdataset Registry
- American Thrombosis and Hemostasis Network, Hickory
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 21. apr. 2026 · NCT06820515Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- Levine Children's Hospital - Hematology, Charlotte
RekruttererFase 3
Alder 12 til 35 · Alle køn · Opdateret 23. mar. 2026 · NCT05477563Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Duke University Medical Center, Durham
RekruttererFase 2
Alder 15 til 40 · Alle køn · Opdateret 13. mar. 2026 · NCT06260891Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Levine Children's Hospital, Charlotte
RekruttererFase 2
Alder 2 til 25 · Alle køn · Opdateret 10. mar. 2026 · NCT03587272Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Wake Forest Baptist Hospital, Durham
- East Carolina University Health Medical Center, Greenville
Rekrutterer
Alder 16 til 30 · Alle køn · Opdateret 7. jan. 2026 · NCT06374238Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.